Correlation Between DIO and AptaBio Therapeutics
Can any of the company-specific risk be diversified away by investing in both DIO and AptaBio Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining DIO and AptaBio Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between DIO Corporation and AptaBio Therapeutics, you can compare the effects of market volatilities on DIO and AptaBio Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in DIO with a short position of AptaBio Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of DIO and AptaBio Therapeutics.
Diversification Opportunities for DIO and AptaBio Therapeutics
-0.09 | Correlation Coefficient |
Good diversification
The 3 months correlation between DIO and AptaBio is -0.09. Overlapping area represents the amount of risk that can be diversified away by holding DIO Corp. and AptaBio Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AptaBio Therapeutics and DIO is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on DIO Corporation are associated (or correlated) with AptaBio Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AptaBio Therapeutics has no effect on the direction of DIO i.e., DIO and AptaBio Therapeutics go up and down completely randomly.
Pair Corralation between DIO and AptaBio Therapeutics
Assuming the 90 days trading horizon DIO Corporation is expected to under-perform the AptaBio Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, DIO Corporation is 2.4 times less risky than AptaBio Therapeutics. The stock trades about -0.05 of its potential returns per unit of risk. The AptaBio Therapeutics is currently generating about 0.01 of returns per unit of risk over similar time horizon. If you would invest 742,000 in AptaBio Therapeutics on September 5, 2024 and sell it today you would lose (81,000) from holding AptaBio Therapeutics or give up 10.92% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
DIO Corp. vs. AptaBio Therapeutics
Performance |
| Timeline |
| DIO Corporation |
| AptaBio Therapeutics |
DIO and AptaBio Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with DIO and AptaBio Therapeutics
The main advantage of trading using opposite DIO and AptaBio Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if DIO position performs unexpectedly, AptaBio Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AptaBio Therapeutics will offset losses from the drop in AptaBio Therapeutics' long position.The idea behind DIO Corporation and AptaBio Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.| AptaBio Therapeutics vs. ABL Bio | AptaBio Therapeutics vs. Helixmith Co | AptaBio Therapeutics vs. OliX PharmaceuticalsInc | AptaBio Therapeutics vs. Oscotec |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Other Complementary Tools
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |